tiprankstipranks
Trending News
More News >
BioVersys AG (CH:BIOV)
:BIOV
Switzerland Market
Advertisement

BioVersys AG (BIOV) Stock Forecast & Price Target

Compare
0 Followers
See the Price Targets and Ratings of:

BIOV Financial Forecast

No data currently available

BIOV Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.
No data currently available

BIOV Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi Analyst forecast on CH:BIOV
Jelena Milovic
Citi
Not Ranked
Citi
CHF62
Buy
153.06%
Upside
Initiated
04/04/25
Citi starts BioVersys AG (BIOV:SW) at BuyCiti analyst Jelena Milovic initiates coverage on BioVersys AG (BIOV:SW) with a Buy rating and a price target of CHF62.00.
Stifel Nicolaus Analyst forecast on CH:BIOV
Stifel Nicolaus
Stifel Nicolaus
CHF70
Buy
185.71%
Upside
Reiterated
03/26/25
BioVersys AG: Positioned for Growth with Strong Financials and Promising Pipeline
UBS
CHF48
Buy
95.92%
Upside
Initiated
03/20/25
UBS Starts BioVersys AG (BIOV:SW) at BuyUBS analyst Xian Deng initiates coverage on BioVersys AG (BIOV:SW) with a Buy rating and a price target of CHF48.00.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi Analyst forecast on CH:BIOV
Jelena Milovic
Citi
Not Ranked
Citi
CHF62
Buy
153.06%
Upside
Initiated
04/04/25
Citi starts BioVersys AG (BIOV:SW) at BuyCiti analyst Jelena Milovic initiates coverage on BioVersys AG (BIOV:SW) with a Buy rating and a price target of CHF62.00.
Stifel Nicolaus Analyst forecast on CH:BIOV
Stifel Nicolaus
Stifel Nicolaus
CHF70
Buy
185.71%
Upside
Reiterated
03/26/25
BioVersys AG: Positioned for Growth with Strong Financials and Promising Pipeline
UBS
CHF48
Buy
95.92%
Upside
Initiated
03/20/25
UBS Starts BioVersys AG (BIOV:SW) at BuyUBS analyst Xian Deng initiates coverage on BioVersys AG (BIOV:SW) with a Buy rating and a price target of CHF48.00.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering BioVersys AG

1 Month
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-4.90%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -4.90% per trade.
3 Months
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-2.40%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -2.40% per trade.
1 Year
Clémence ThiersStifel Nicolaus
Success Rate
0/1 ratings generated profit
0%
Average Return
-28.50%
reiterated a buy rating 5 months ago
Copying Clémence Thiers's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -28.50% per trade.
2 Years
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-28.50%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -28.50% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BIOV Analyst Recommendation Trends

Rating
Mar 25
Apr 25
Strong Buy
2
3
Buy
1
1
Hold
0
0
Sell
0
0
Strong Sell
0
0
total
3
4
In the current month, BIOV has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. BIOV average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

BIOV Stock Forecast FAQ

What is CH:BIOV’s average 12-month price target, according to analysts?
Currently, no data Available
What is CH:BIOV’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CH:BIOV, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is BioVersys AG a Buy, Sell or Hold?
      Currently, no data Available
      What is BioVersys AG’s share price target?
      Currently, no data Available
      What do analysts say about BioVersys AG?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of BioVersys AG?
      To buy shares of CH:BIOV, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis